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 ZNF675 is a primate-specific KRAB-ZNF protein that arose in the last common ancestor of New 
World Monkeys and Old World Monkeys. It represses THE1 and MST families of retrotransposons and 
binds to gene promoters like MCPH1 and SESN3. Copy-number variation of ZNF675 is associated with 
neurological disorders, including microcephaly and intellectual disability. Unravelling the evolutionary 
history and the regulatory effect of ZNF675 will clarify its role in primates’ evolution. 
 The analysis of ZNF675 sequence revealed a significant difference in zinc-finger domains 
between the marmoset and the human ZNF675. In a reporter assay, the marmoset ZNF675 did not bind 
to MSTA elements. However, the human ZNF675 had a strong repressive effect on them. This indicates 
structural changes in ZNF675 emerged to silence THE1 and MST retrotransposons, after New World 
Monkeys split from our last common ancestor. As a collateral effect, ZNF675 created a new regulatory 
network, by binding to gene promoters, 25% of which are involved in development and neuronal 
processes. At the same time, some ZNF675 binding sites in gene promoters also underwent changes, 
as found in the MCPH1 and SESN3 promoters. These changes affect the ZNF675 binding capacity and 
led to the evasion or stabilization of its regulatory function. This highlights the dynamics of genome 
evolution in primates. 
 To further investigate these findings, the CRISPR/Cas9 system was used for targeted deletion 
of ZNF675 and ZNF681, or for modifying promoter region sequences using homology-directed repair. 
 The evolutionary arms race between ZNF675 and THE1 and MST elements led to the creation 
of a novel ZNF675, with the ability to silence them. As a collateral consequence, ZNF675 binds to gene 
promoters, regulating their expression. This new regulation network might have had a strong impact on 
the evolution of the human brain. 
 
 












O ZNF675 pertence à família das proteínas KRAB-ZNF e surgiu há 35 milhões de anos, no 
último ancestral comum dos Macacos do Novo e do Velho Mundo. Esta proteína silencia 
especificamente retrotransposões das famílias THE1 e MST, mas também pode ligar-se a promotores 
de genes neuronais como o MCPH1 e o SESN3. Variações no número de cópia do ZNF675 estão 
associadas a doenças neurológicas como microcefalia e deficiência intelectual. Este projeto pretende 
desvendar a função do ZNF675 no genoma humano e a sua história evolutiva.  
 A análise de sequências do ZNF675 ao longo da evolução revelou uma diferença significativa 
entre o domínio de zinc-fingers do ZNF675 presente no primata sagui-de-tufos-brancos e no de 
humanos. Num luciferase reporter assay, o ZNF675 do sagui-de-tufos-brancos não se ligou ao 
retrotransposão MSTA. Contudo, o ZNF675 humano exerceu uma forte repressão no mesmo. Isto 
indica que as alterações estruturais no ZNF675 evoluíram no sentido de silenciar os retrotransposões 
THE1 e MST, depois da divergência dos Macacos do Novo Mundo com o nosso último ancestral 
comum. Consequentemente, o ZNF675 terá adquirido uma nova função regulatória ao ligar-se a 
promotores de genes, alguns dos quais foram sofrendo alterações ao longo da evolução dos primatas. 
Estas alterações levaram a uma evasão ou estabilização de função regulatória do ZNF675. 
 Para investigar esta ideia, uma deleção nos genes ZNF675 e ZNF681 foi gerada através da 
técnica CRISPR/Cas9, e conjuntamente com o mecanismo de homology-directed repair, para modificar 
sequências dos promotores. 
 Os resultados descritos sugerem que a luta evolutiva entre KRAB-ZNFs e os retrotransposões 
THE1 e MST terá levado à emergência do ZNF675, que passou a silenciar estes elementos. 
Colateralmente, o ZNF675 também começou a regular genes envolvidos no desenvolvimento 
neurológico devido à afinidade pelo seu promotor. Esta regulação colateral poderá ter tido um forte 
impacto na evolução do cérebro humano. 
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1.1 Evolution of the human brain 
 The human brain has increased remarkably in size and complexity throughout primate evolution. 
The encephalization quotient, a way of measuring brain size relatively to body weight, differs significantly 
between human and other primates, which is not observed when comparing nonhuman primates 
(Williams, 2002). In fact, the human brain has undergone an overdevelopment, specifically the neocortex 
and cerebellum, that has been correlated to an increase in cell populations (Herculano-Houzel, Collins, 
Wong, & Kaas, 2007). A lot of effort has been devoted to find the underlying causes of the human brain 
singularity, i.e. the genetic and molecular events that led to a bigger-than-expected brain throughout 
primate evolution. 
In order to search for the genetic basis of brain evolution in primates, differences between 
humans and chimpanzees have been investigated. In 1975, Mary-Claire King and Allan Wilson 
published a landmark article that shed light on the molecular differences and similarities of humans and 
chimpanzees, where they found that both primates share more than 99% of the average polypeptide 
coding sequence (King & Wilson, 1975). Even though years later it was described that the difference 
between these two species is in fact 4% (Varki & Altheide, 2005), such a small change could not explain 
their major anatomical and behavioural differences. However, together with the non-coding part of the 
genome, important regulatory regions which control gene expression, and structural genomic 
rearrangements might have had an impact on the emergence of the human species.  
Brain evolution has been linked to natural selection and genome reshaping, of which 
Transposable Elements (TEs) are a major cause (Ayarpadikannan & Kim, 2014; Cordaux & Batzer, 
2009; Deininger, Moran, Batzer, & Kazazian, 2003). TEs are derived from ancient viruses that infected 
the host millions of years ago (Mya). They were first described by the Nobel Prize Barbara McClintock, 
being referred to as “controlling elements” because they are able to regulate gene expression 
(McClintock, 1950). They have the unique ability of moving throughout the genome, or even between 
genomes (Cordaux & Batzer, 2009), which is also the reason why between half (Lander et al., 2001) 
and two-thirds (de Koning, Gu, Castoe, Batzer, & Pollock, 2011) of the human genome is composed of 
TEs. 
Krüppel-associated box zinc-fingers (KRAB-ZNF) proteins function as transcriptional repressors 
of TEs, in a type-specific manner, to prevent transposition and, thereby, maintain genome integrity 
(Imbeault, Helleboid, & Trono, 2017; Jacobs et al., 2014; Najafabadi et al., 2015). These proteins 
constitute ~50% of human zinc-finger (ZNF) proteins, representing the largest and most rapidly evolving 
gene family (Huntley et al., 2006; Najafabadi et al., 2015). They have been described as a driving force 
of a new level of gene regulation in primates, in a species-specific manner (Hamilton, Huntley, Gordon, 
& Stubbs, 2005; Imbeault et al., 2017; Jacobs et al., 2014; Nowick, Hamilton, Zhang, & Stubbs, 2010; 
Shannon, Hamilton, Gordon, Branscomb, & Stubbs, 2003). Interestingly, KRAB-ZNF (KZNF) proteins 




It was proposed that these regulatory modifications were in part responsible for the humans’ over-sized 
and more complex brain (Nowick, Gernat, Almaas, & Stubbs, 2009). 
 
 
1.2 Transposable elements 
 TEs are grouped in two major classes according to their transposition mechanism: class 1 and 
class 2. Class 2 is composed of transposons, DNA elements that can excise and insert themselves into 
another region of the genome, which constitute ~3% of the human genome (Pace, Feschotte, & Ii, 2007). 
Class 1 comprises TEs which make use of an RNA intermediate to transpose. For this reason, they are 
called retrotransposons. A reverse transcriptase, encoded in the element itself, copies the RNA into 
complementary DNA (cDNA) which then gets integrated in another region of the genome. Within this 
class, TEs can even be divided in families based on the presence or absence of long terminal repeats 
(LTRs): LTR retrotransposons (Figure 1.01), also known as human endogenous retroviruses (HERVs), 
are similar to simple retroviruses, lacking only the envelope-coding gene, and constitute ~8% of human 
genome (Deininger et al., 2003). In contrast, non-LTR retrotransposons, which do not contain an LTR 
region, are further subdivided in long interspersed elements (LINEs) and short interspersed elements 
(SINEs), e.g. L1 and Alu elements, respectively. There is also a hominoid-specific element family, the 
SVA elements, which comprise a SINE region, followed by a variable number of tandem repeats (VNTR) 









Figure 1.01 – Schematic of retrotransposable elements. Retrovirus is composed of three genes: gag (group-
specific antigen), pol (reverse transcriptase) and env (envelope protein). LTR retrotransposons are similar, lacking 
only the env gene. Non-LTR retrotransposons (primarily LINEs in mammals) have an RNA polymerase II promoter, 
allowing the transcription of a full-length RNA that encodes two proteins: ORF1 and ORF2. Non-autonomous 
retroposons (primarily SINEs in mammals) have an RNA polymerase III promoter (A and B boxes) to transcribe a 







Retrotransposons are the major creators of genome instability by inserting themselves within or 
close to genes, or by inducing genomic ectopic rearrangements (Ayarpadikannan & Kim, 2014; Cordaux 
& Batzer, 2009; Lander et al., 2001). They can cause deleterious mutations when inserted in an exon, 
which might change the open reading frame (ORF) giving rise to non-functional proteins. TEs can also 
cause abnormal proteins, if they get inserted in an intron, eliminating the canonical splice site or even 
creating novel splice sites (Ayarpadikannan & Kim, 2014). On the other hand, TEs can generate ectopic 
rearrangement events, such as deletions, duplications and inversions, creating new genes, modifying 
pre-existing ones or just changing the GC content (Lander et al., 2001). Moreover, if TEs get inserted in 
close proximity with genes, in regulatory regions, they can change their expression levels, thus altering 
the network on which that gene acts on (Ayarpadikannan & Kim, 2014). Interestingly, genomic 
modifications induced by TEs are proposed to have accelerated evolution of gene regulatory networks 
over mammalian evolution (Lowe, Bejerano, & Haussler, 2007). 
With the sequencing of the human genome it was possible to estimate TEs’ activity status during 
primate evolution, by analysing the sequence divergence between species. It was shown that the activity 
of all transposons has declined 35-50 Mya, which means that they were active during early primate 
evolution (Lander et al., 2001). This includes some families of LTR (THE1A, THE1B, THE1C, MSTA 
and MSTB) and non-LTR retrotransposons (L1 and Alu elements), since they are primate-specific 
(Cordaux & Batzer, 2009; Pace et al., 2007). On the contrary, SVA elements have been active only 
during the hominid evolution. Some families of SVA, L1 and Alu elements are still active in the human 
genome (Mills, Bennett, Iskow, & Devine, 2007; H. Wang et al., 2005). Interestingly, they have been 
associated with a variety of genetic diseases, such as certain types of cancer, haemophilia and X-linked 
diseases (Deininger et al., 2003; Kazazian, 1998; Konkel & Batzer, 2010). However, TEs have also 
been described to play an important role in early development, being involved in essential processes 
such as in placental formation, meiotic recombination during gametogenesis and epigenetic inheritance 
(Gifford, Pfaff, & MacFarlan, 2013). 
 
 
1.3 Krüppel-associated box zinc-finger proteins 
 KZNF proteins, the TEs’ transcriptional repressors, are composed of C2H2-like ZNFs, which is 
the most prevalent DNA-binding motif of transcription factors (TFs) in eukaryotic organisms (Huntley et 
al., 2006; Thomas & Schneider, 2011). ZNF proteins often have between 1 and 30 ZNF motifs in tandem 
arrays, each one with two cysteines and two histidines interacting with a zinc ion, stabilizing the structure 
(Huntley et al., 2006; Krishna, Majumdar, & Grishin, 2003). These ZNF motifs consist of two β-sheets 
and one α-helix (Figure 1.02a), being the last one the DNA-binding domain by fitting in the major groove 
of the DNA (Lupo et al., 2013; Persikov & Singh, 2014). It is proposed that the ZNF protein binds to DNA 
with high specificity, as each ZNF motif contacts four consecutive base pairs (Figure 1.02b), overlapping 
on one, i.e. there is binding of three base pairs per ZNF motif (Persikov & Singh, 2014). There is currently 




influence of amino acids close to those that bind the DNA, the impact of other ZNF motifs or even the 
possibility that not all the motifs bind to DNA (Najafabadi et al., 2015).  
 




Figure 1.02 – Representation of C2H2-like ZNF protein-DNA interaction. (a) Structural model of a protein with 
three ZNF motifs interacting with DNA. Each ZNF motif has two β-sheets (yellow), one α-helix (red/orange) and a 
zinc ion (blue). Adapted from Yang, Wang, & Macfarlan, 2017. (b) Two consecutive ZNF motifs binding to DNA. 
Amino acids within the i-th ZNF are numbered according to their relative position from the start of the alpha helical 
domain. DNA bases b1, b2, b3 and b4 are numbered sequentially and the complementary bases are primed. The 
canonical contacts are shown with solid arrows, and the three additional contacts are shown with dashed arrows. 
Adapted from Persikov & Singh, 2014. 
  
 KZNF proteins are composed of a 75-amino acid KRAB domain in the N-terminal domain, in 
addition to the ZNF domain at the C-terminus. After DNA-binding by the ZNF domain (Figure 1.03), 
repression occurs through interaction of the KRAB domain with the KRAB-associated protein 1 (KAP1, 
or TRIM28) (Peng et al., 2000). The complex recruits SETDB1, a histone 3 lysine 9-specific 
methyltransferase, which in turn enhances heterochromatin protein 1 (HP1) binding (David C Schultz, 
Ayyanathan, Negorev, Maul, & Rauscher Iii, 2002). The nucleosome remodelling and deacetylase 
(NuRD) complex is also recruited by KZNF/KAP1 (D. C. Schultz, Friedman, & Rauscher, 2001), making 
up the repression complex, which induces heterochromatin formation and transcriptional silencing 
(Yang, Wang, & Macfarlan, 2017). The induced chromatin remodelling is spread in a long-range 
repression through H3K9me3 (histone 3 lysine 9-trimethylation) and HP1, model confirmed in a KZNF 






Figure 1.03 – Representation of the KRAB-ZNF protein repression complex. Firstly, ZNF domain binds to the 
DNA and the KRAB domain interacts with KAP1. The complex recruits other factors such as SETDB1, HP1 and the 
NuRD complex. Red circles on histone tails are H3K9m3 and green circles are deacetylation of multiple lysines. 





 KZNF proteins are specific to tetrapod vertebrates and are often localized in familial gene 
clusters, as they are primarily originated by duplication events. For instance, out of 423 KZNF protein-
coding loci, at least 136 are primate-specific KZNF and have diverged significantly after duplication 
(Huntley et al., 2006). Even though these genes coexist in the same loci, each one is under a distinct 
selective pressure, giving rise to novel proteins with new recognition sites, as changes occur mostly in 
the ZNF domain and the smallest nucleotide variation influence DNA binding (Huntley et al., 2006; Lupo 
et al., 2013). Segmental duplications of loci containing KZNF protein-coding genes are also the 
underlying cause for the observed diversity among their families, where 24 KZNF protein-coding genes 
are only present in great apes and hominids. Interestingly, gene duplications that are human and 
chimpanzee-specific have evolved in a higher rate than older genes, which may be evidence for the still 
ongoing evolution of regulatory factors (Nowick et al., 2010).  
KZNF proteins are involved in essential physiological processes, such as development, 
differentiation, metabolism, cell division and cancer (Lupo et al., 2013), in a cell type-specific manner 
(Najafabadi et al., 2015). For instance, ZNF809 is a stem cell-specific retroviral repressor (Wolf & Goff, 
2009); ZNF382 is a proapoptotic tumour suppressor (Cheng et al., 2010); ZNF268 participates in the  
erythroid cells’ differentiation (Zeng et al., 2012); and PRDM9, a well-studied KZNF protein, determines 
meiotic recombination hotspots’ location (Altemose et al., 2017). Moreover, KZNF proteins might have 
a role preventing segmental duplication events by suppressing nonallelic homologous recombination, 
stabilizing the genome (Najafabadi et al., 2015). 
 
 
1.4 Evolutionary arms race between transposable elements and KZNF proteins 
 In 2009, Emerson and Thomas hypothesized that the evolution of KZNF proteins was being 
“driven by an arms race with their viral or transposon targets” (Emerson & Thomas, 2009). The first two 
main evidences that point in that direction were a strong correlation between the number of ZNF 
domains and LTR retrotransposons in the vertebrate genome; and whenever a new endogenous 
retrovirus (ERV) family arose in the genome, it was usually followed by a burst of ZNF genes. (Thomas 
& Schneider, 2011). This model was later supported by Jacobs and colleagues, who have shown that 
retrotransposons would evade repression due to mutations within the binding site of their primate-
specific KZNF (Figure 1.04). In response, KZNF proteins evolved to keep the retrotransposons silenced, 
in an evolutionary arms race (Jacobs et al., 2014). Jacobs et al. showed this through luciferase reporter 
assays in mouse embryonic stem cells (mESC). An SVA element was cloned upstream of a minimal 
SV40 promoter, which controls the expression of the luciferase reporter. The constructs were co-
expressed with different versions of the ZNF91: the human, the version probably present in the last 
common ancestor (LCA) of humans and gorillas, in the LCA of humans and orangutans, and the 
macaque version. The experiment revealed a difference in luciferase activity, being strongly repressed 
with the human ZNF91, and having a decreasing effect in the older species. This implies that the 












Figure 1.04 – Evolutionary arms race between KZNF proteins and retrotransposons. Retrotransposons have 
the ability to transpose to another location in the genome until a KZNF protein emerges and silences them. Later, 
retrotransposons escape repression due to mutations. KZNF protein mutates too, recovering the ability to silence 
the retrotransposons. Adapted from Frank Jacobs, frankjacobslab.com (retrieved in: 20/09/2018). 
 
 KZNF proteins have been protecting our genome integrity against transposable elements’ 
emergence since 100 Mya, in the early mammalian radiation (Najafabadi et al., 2015). Throughout 
evolution the ZNF domain of KZNF proteins have undergone significant changes, whilst the KRAB 
domain stayed conserved, meaning that recently emerged TEs can be silenced by the same KAP1-
mediated repression complex (Huntley et al., 2006; Thomas & Schneider, 2011). These DNA-binding 
proteins make up a suitable and smart way of fighting TEs movement, preventing whole-genome 
instability.  
 The arms race can explain in part the rapid expansion of KZNF protein families, but not entirely 
since the majority of TEs have lost the transposition potential and the correspondent KZNF protein still 
has its full binding capacity (Imbeault et al., 2017). As a collateral consequence of the evolutionary 
battle, these family of repressors have acquired novel regulatory functions. They are involved in 
regulation of gene expression, acting either directly by binding promoter regions (Lupo et al., 2013), or 
indirectly by binding TEs, which they benefit from and use as regulatory platforms nearby genes 
(Imbeault et al., 2017; Najafabadi et al., 2015).  
 
 
1.5 ZNF675 and its target genes 
 ZNF675 is a KZNF gene which is expressed in the brain according to the Genotype-Tissue 
Expression (GTEx) project (Lonsdale et al., 2013). According to DECIPHER (Firth et al., 2009), it is 
associated with several neuronal disorders, such as microcephaly, macrocephaly, intellectual disability, 
autism and cerebellar atrophy. Like many other KZNF proteins, ZNF675 is a primate-specific protein 




1.05) (Imbeault et al., 2017). However, a duplication event occurred in the ancestor of humans and 
OWMs, giving rise to ZNF681, with a quite different DNA recognizing ZNF domain. Furthermore, 
ZNF675 itself underwent significant structural modifications, which changed its DNA-recognizing motifs 









Figure 1.05 – Evolutionary history of ZNF675. ZNF675 first arose in the LCA of NWMs and OWMs. It underwent 
a duplication event in the LCA of OWM and apes, giving rise to ZNF681. Adapted from Lodewijk et al., unpublished. 
 
 ZNF675 represses LTR retrotransposons, specifically THE1B/C/D/A (transposon-like human 
element 1) and MSTA/B/B1 (Najafabadi et al., 2015), acting in a cell-type specific manner (Imbeault et 
al., 2017). Interestingly, it appears that a great expansion of THE1 and MST elements happened in the 
LCA of NWM and OWM, which was right before the structural changes of ZNF675 (Lodewijk et al., 
unpublished). 
Chromatin immunoprecipitation sequencing (ChIP-seq) is a technique widely used to detect the 
interactions between DNA and proteins, and allows the identification of the DNA sequence involved, i.e. 
the binding site (Schmidt et al., 2009). ChIP-seq data for ZNF675 (GEO accession number: 
GSM1407624) (Najafabadi et al., 2015), suggests that besides binding TEs, ZNF675 binds to several 
genes related to neurodevelopment or involved in neurological disorders such as HES1 (hairy and 
enhancer of split homolog 1), MCPH1 (microcephalin 1) and SESN3 (sestrin 3). 
 HES1 is a transcription factor involved in the regulation of the central nervous system 
development, by maintaining neuronal progenitors’ self-renewal and proliferative capacity (Nakamura et 
al., 2000). Preserving the neuroprogenitors’ pool is crucial to reach the correct number of neuronal cells, 
which is accomplished by HES1 repression of the cyclin-dependent kinase inhibitor p27Kip1 (Murata et 
al., 2005).  
MCPH1 is considered a pleiotropic factor, since it has a broad range of different functions. It is 
implicated in DNA damage repair, genomic stability, chromatin remodelling and cell division, by 
regulating the G2/M checkpoint (Liu, Zhou, & Wang, 2016) and the chromosomes biorientation (Arroyo 




including lung and breast cancer (Mantere et al., 2016; Zhou et al., 2016). MCPH1 plays an important 
role in regulating brain size during development, being the first gene to be associated with primary 
microcephaly. Microcephaly is a disorder characterized by a small brain, specifically the cerebral cortex, 
and a head circumference with more than 3 standard deviations below the age-related mean (Jackson 
et al., 2002). Genes involved in brain development are of particular interest since they might have played 
a role in humans’ brain enlargement during evolution. In fact, several studies concerning MCPH1 gene 
have suggested that it was under positive selection in the lineage from OWMs ancestor to humans and 
great apes, especially after the split of lesser apes (Evans, Anderson, Vallender, Choi, & Lahn, 2004; 
Y. Q. Wang & Su, 2004).  
 SESN3 gene is a member of the highly conserved Sestrins family, characterized by having 
antioxidant properties. It is regulated by FoxO, subfamily of forkhead transcription factors, in response 
to high levels of reactive oxygen species (ROS) induced by Ras proteins. Therefore, SESN3 have a 
determinant role against oxidative stress and in preventing apoptosis (Hagenbuchner et al., 2012; 
Nogueira et al., 2008). In case of disease, the protective activity of SESN3 is especially important, which 
is why this protein has been described to act in certain types of diseases, such as cancer (colorectal 
and lung cancer), metabolism disorders, diabetes and cardiovascular disorders (M. Wang et al., 2018). 
However, regarding the brain, SESN3 has been associated with epilepsy. In the human epileptic 
hippocampus, SESN3 was found to act as a trans-acting genetic control of a proconvulsant gene-
regulatory network, which positively regulates proconvulsive cytokines and Toll-like receptor signalling 
gene (Johnson et al., 2015). 
 Genes involved in major cellular processes need to be under a strict chronological and spatial 
regulatory mechanism in order to be expressed in a controlled manner. Consequently, changes in the 
regulatory machinery have a strong impact on gene expression, thus altering the downstream process 
that gene would act on. The LCA of humans and NWMs was probably the first primate suffering from 
the regulatory changes caused by the ZNF675 emerging, around 35 Mya.  
 
 
1.6 Aim of this study 
 It is hypothesised that ZNF675 arose in the genome to repress THE1 and MST elements, but 
the promoters of several genes were caught in the arms race, such as HES1, MCPH1 and SESN3. 
Here, ZNF675 repression of MCPH1 and SESN3 is investigated in the context of evolution. By exploring 
how ZNF675 structural changes might have affected its DNA binding capacity and how small 
modifications in the promoters of these genes over the past millions of years have fine-tune the binding. 
ZNF675 structural changes over time are investigated with the Princeton predictive DNA recognition 
tool (Persikov & Singh, 2014), where DNA motifs recognized by ZNF675 are unravelled. The human 
ZNF675 and marmoset ZNF675 binding affinity to the MCPH1 and SESN3 promoter regions is analysed 




promoters’ changes during primate evolution are assessed with a multiple sequence alignment of 
sequences from NWMs or basal primates to humans. To further investigate these findings, the 
CRISPR/Cas9 system is used to induce a targeted deletion of the ZNF675 and ZNF681 genes. This 
technique is also used, together with the homology-directed repair (HDR) mechanism, to change the 
ZNF675 binding site in human cells by the marmoset. Finally, a chromatin immunoprecipitation (ChIP) 
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2 Materials and methods 
 
2.1 ZNF675 and ZNF681 structural analysis  
 The ZNF675 sequences from human (hZNF675), crab-eating macaque (mZNF675) and 
marmoset (cZNF675), and the ZNF681 from human (hZNF681) and crab-eating macaque (mZNF681), 
were previously obtained through the analysis of sequences from the Whole-Genome Shotgun contigs 
on GenBank, NCBI. Using the predictive DNA recognition tool (Persikov & Singh, 2014), ZNF motifs of 
ZNFs were characterized as functional, if the ZF score was higher than 25, or degenerated, and on 
which DNA motifs they bind to. With that information, the structural changes of all ZNFs were analysed. 
 
 
2.2 Analysis of ZNF675 binding to THE1B-int elements  
 Using the RepeatMasker from the UCSC Genome Browser (Kent et al., 2002), all the THE1B-
int sequences, which is the internal part of the elements, were obtained from the human reference 
genome GRCh37/hg19. Sequences were filtered by sequence similarity score above 8000 and length 
greater than 800bp. In order to get the THE1B-int elements that are bound and not bound by ZNF675, 
the selected sequences were intersected with Model-based Analysis of ChIP-seq (MACS) peak calling 
data from the ChIP-seq data for ZNF675 (GEO accession number: GSM1407624) (Najafabadi et al., 
2015). ZNF675-bound was defined as 50% of the ZNF675 peak was overlapping with a THE1B-int 
element, whereas unbound was defined as no overlap at all. From the bound 641 and unbound 1505 
THE1B-int elements, 15 sequences with the higher score of each group were aligned using the Multiple 
Sequence Alignment MUSCLE in UGENE (Okonechnikov et al., 2012). 
 
 
2.3 ZNF675 ChIP-seq data for promoter binding analysis  
 Previously, raw ZNF675 ChIP-seq data fastq files (GSM2466628, GSM1407624) (Imbeault et 
al., 2017; Najafabadi et al., 2015) were trimmed with Trimmomatic using the following parameters: 
ILLUMINACLIP Truseqv3 single end for Hiseq, SLIDNIGWINDOW: 4:20, MINLEN: 30. Then, reads 
were mapped to hg19 or hg38 using Bowtie2, using very sensitive end-to-end settings. The BAM files 
were converted to bigwig using DeepTools bamCoverage (bin size = 1). Bigwig files were analysed 
using the UCSC genome browser. Using the table browser, bigwig files were filtered for regions with 
sequencing depth of >20 reads. Promoter regions were selected from 5kb upstream of genes’ 
transcription start site (TSS) until 1kb downstream. Both promoter regions and the filtered bigwig files 
were intersected with any percentage of overlap. From the output list of intersections, regions with a lot 
of noise were excluded. Genes being influenced by the ZNF675 were annotated, as any class of repeats, 
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long non-coding RNA, antisense RNA and small nuclear RNA, if the ZNF675 binding site was in those 
elements. The list was further shortened by selecting neuronal related genes, involved in cell signalling 
or associated with neuronal diseases. 
 
 
2.4 Retinoic Acid treatment of a human neuroblastoma cell line 
 Cells from the human neuroblastoma cell line SK-N-SH (Sigma-Aldrich #86012802) were 
seeded at a density of 5 x 104 cells per well in 2x 12-wells plates and grown in minimum essential 
medium (MEM, ThermoFisher Scientific #31095029) with 10% heat inactivated fetal bovine serum 
(HiFBS, ThermoFisher Scientific #10500-064) and 1x penicillin/streptomycin (P/S, ThermoFisher 
Scientific #15140122). After 24 hours (T0) cells were isolated in TRIzol (ThermoFisher Scientific 
#15596018) and kept in –80°C. Cells still in culture were treated with 10µM retinoic acid (RA, Sigma-
Aldrich #R2625) or ethanol (Merck Millipore #1.00983.1000) as control. 24 hours later, cells were 
isolated in TRIzol and the RNA extracted, including from the T0 cells, following the Direct-zolTM RNA 
MicroPrep protocol (Zymo Research). A one-step RT-PCR (QIAGEN) was performed according to the 
manufacturer’s protocol, on 20ng of RNA per reaction, with a program of 25 cycles. The following 
primers were used: 
HES1_qFw1: GATGCTCTGAAGAAAGATAGC  HES1_qRv1: TTCATGCACTCGCTGAAGC 
 The amplicons were analysed on a 1% agarose gel electrophoresis and the relative density of 
the DNA was analysed using ImageJ (Abràmoff, Magalhães, & Ram, 2004). 
 
 
2.5 MCPH1 and SESN3 promoter region in primates 
 MCPH1 and SESN3 promoter sequences were obtain from the human reference genome 
GRCh37/hg19 on the UCSC Genome Browser. The sequences were then converted to other primate’s 
genomes, being further described in the following table: 
Table 2.01 – Description of each primate species used on the analysis. The columns from the first until the fifth 
correspond to: primate’s group, primate’s name, genome assembly used, coordinates of the sequence used of the 
MCPH1 and SESN3 genes’ promoters. 
  Genome Assembly MCPH1 Coordinates SESN3 Coordinates 









































































































Bushbaby Broad/otoGar3 – 
GL873520:268,417-
270,652 
 The sequences were aligned using the Multiple Sequence Alignment MUSCLE in UGENE and 
their conservation was analysed. 
 
 
2.6 Luciferase Reporter Assay on human and marmoset MCPH1 and SESN3 promoters 
 Cloning of sequences into pGL3 vector – A promoter region of 200bp from human and 
marmoset MCPH1 and SESN3 were obtained on the UCSC Genome Browser, further characterized in 
the following table: 
Table 2.02 – Description of human and marmoset promoter regions of MCPH1 and SESN3. First column 
corresponds to the primate’s name, second is the genome assembly used, third and fourth are the coordinates fo 
the sequences used of the MCPH1 and SESN3 genes’ promoters. 
 Genome Assembly MCPH1 coordinates SESN3 coordinates 
Human GRCh37/hg19 chr8:6,263,654-6,263,853 chr11:94,964,744-94,964,943 
Marmoset WUGSC 3.2/calJac3 chr13:5,721,612-5,721,811 chr11:42,484,350-42,484,543 
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 These sequences were repeated 3 times and the following restriction sites were added: KpnI at 
the 5’ end, and XhoI or BglII for the 3’ end. The constructs were synthesized by GeneArt from 
ThermoFisher Scientific and cloned into a pGL3-Promoter luciferase vector (Promega #E1761). Ligation 
and transformation were done following the Quick ligation kit recommended protocol. pGL3-hMCPH1, 
pGL3-cMCPH1, pGL3-hSESN3 and pGL3cSESN3 were Sanger sequenced. 
 
 Cell Transfection and Luciferase Assay – Mouse 46c embryonic stem cells (Ying, Stavridis, 
Griffiths, Li, & Smith, 2003) were seeded from a full 100mm dish in a dilution of ¼ cells per well, in 24-
wells plate coated with 0.1% gelatin. The cells were cultured in Glasgow's MEM (GMEM, ThermoFisher 
Scientific #11710-035) complete (10% HiFBS, 1x P/S, 5.5nM β-mercaptoethanol (ThermoFisher 
Scientific #31350010) 1x Non-essential aminoacids (ThermoFisher Scientific #11140035) and 1x 
sodium pyruvate (ThermoFisher Scientific #11360039)) supplemented with 1x leukemia inhibitory factor 
(LIF, ESGRO/Merck Millipore #ESG1106). On the following day the medium was changed to GMEM 
complete without P/S. Cells were transfected using LipofectamineTM 3000 reagent (ThermoFisher 
Scientific), according to the manufacturer’s recommended protocol. The transfection mix per well was 
composed of 5ng Red Fluorescent Protein (RFP), 5ng pRenilla (Promega #E2231) and 50ng pGL3 
luciferase vector: pGL3-EV, pGL3-MSTA (previously cloned), pGL3-hMCPH1, pGL3-mMCPH1, pGL3-
hSESN3 or pGL3-mSESN3. Per luciferase vector, it was added 440ng pCAG-EV (with 90ng 
pBluescript), pCAG-hZNF675-HA or pCAG-mZNF675-HA. 6 hours after the transfection the medium 
was changed again to GMEM complete with 1x LIF. On the next day the cells were washed once with 
Phosphate Buffered Saline (PBS, Lonza BioWhittaker™ #BE17-516F/12) and lysed using 100µl Passive 
Lysis Buffer from Dual-Luciferase® Reporter Assay System (Promega). The cell suspension was 
incubated for 15min incubation on an orbital shaker (250rpm) at room temperature and for 15min at -




2.7 Cloning of ZNF675-EGFP and ZNF681-EGFP fusion constructs 
 The enhanced green fluorescent protein (eGFP) was amplified by a PCR on pCAG-eGFP 
expression vector (Addgene #11150), with Phusion High-Fidelity DNA Polymerase (ThermoFisher 





pEGFP_ZNF675_NotI_R1: AGCTGCGGCCGCTCACTTGTACAGCTCGTCCATGCCG  
Hereafter, the underlined sequence is the restriction site. 
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 PCR products were analysed on a 1% agarose gel electrophoresis. Amplicons were excised, 
and DNA was extracted using QIAEX II Gel Extraction kit (QIAGEN).  
 The human, crab-eating macaque and marmoset ZNF675 coding sequences were previously 
obtained through the analysis of sequences from the Whole-Genome Shotgun contigs on GenBank, 
NCBI. An HA-tag sequence was added to the end of each ZNF and the constructs were synthesized by 
GeneArt from ThermoFisher Scientific. The vectors and the eGFP fragment were digested with the 
restriction enzymes: PstI (ThermoFisher Scientific, #ER0611) for pMA-hZNF675-HA; NdeI 
(ThermoFisher Scientific #ER0581) for pMA-mZNF675-HA, pMA-cZNF675-HA and pMA-hZNF681-HA; 
and NotI (ThermoFisher Scientific #ER0591) for every construct. The digested fragments were analysed 
with 1% agarose gel electrophoresis, the DNA excised and extracted using QIAEX II Gel Extraction kit. 
The vectors were treated with Alkaline Phosphatase (New England Biolabs #M0371S) and purified with 
DNA Clean & Concentrator-5 Kit (Zymo Research). The linearized vectors were ligated with the eGFP 
fragment in a 1:10 molar ratio using the Quick ligation kit (New England Biolabs). Competent E.coli 
DH5α was transformed with the construct following the manufacturer’s recommended protocol. Bacteria 
was grown overnight in Luria-Bertani (LB)– agar plates (Merck Millipore #1.10285.0500, VWR 
Chemicals #84609.05) at 37°C. On the next day colonies were picked and grown in LB medium with 
ampicillin (Roche #10835242001) overnight. The plasmids were then isolated from the bacteria using 
the Plasmid Miniprep Kit (QIAGEN). The constructs were cloned into the pCAG expression vector 
(Addgene #51142) using the restriction enzymes EcoRI (ThermoFisher Scientific #ER0271) and NotI, 
for the 5’ and 3’ end, respectively. Finally, the pCAG-hZNF675-GFP, pCAG-mZNF675-GFP, pCAG-
cZNF675-GFP and pCAG-hZNF681-GFP were Sanger sequenced. 
 
 
2.8 MCPH1 promoter region on different primate species 
 Genomic DNA from Chimpanzee, Gorilla, Orangutan, Rhesus Macaque, Baboon, Gibbon and 
Marmoset were obtained from the Biomedical Primate Research Centre, in Rijswijk. Primers were 
designed in the MCPH1 promoter of every primate, which are the following: 
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 Genomic regions of 1200bp were amplified with Phusion High-Fidelity DNA Polymerase on 
20ng genomic DNA (gDNA) per reaction. PCR products were analysed on a 1% agarose gel 
electrophoresis. Amplicons were extracted from gel using the QIAEX II Gel Extraction kit and purified 
with DNA Clean & Concentrator-5 Kit. A second PCR was performed, with the same DNA Polymerase, 
with primers with restriction sites, as shown below: 
MCPH1_Prom-KpnI_F2_AllPrimates: ATGCGGTACCAAGTACGTGAGTCTTCAATG 
MCPH1_Prom-NheI_R2_GreatApes (human, chimp, gorilla): ATGCGCTAGCTTTCCGGGATTTCTCTGTAGG 
MCPH1_Prom-NheI _R2_Baboon: ATGCGCTAGCTTCCGGGATTTGTCTGTAGC 
MCPH1_Prom-NheI _R8_Rhesus: ATGCGCTAGCTTCCGGGATTTATCTGTAGC 
MCPH1_Prom-NheI _R3_Orangutan: ATGCGCTAGCTTTCCGGGATTTCTTTGTAGG 
MCPH1_Prom-NheI _R4_Gibbon: ATGCGCTAGCTTTCCGGGATTTCTCTAGGTG 
 The amplicons were analysed on a 1% agarose gel electrophoresis and excised from the gel. 
 
 
2.9 Replacement of human ZNF675 binding site in the MCPH1 promoter by the marmoset  
 Cloning of guide RNAs into pX330 vector – The guide RNAs (gRNAs) were designed upstream 
and downstream of the ZNF675 binding site in the MCPH1 promoter. To clone unidirectionally, on the 
5’ end of both sense (s) and antisense (as) oligos an overhang was added that can hybridize with DNA 
ends created when digesting pX330-U6-Chimeric_BB-CBh-hSpCas9 vector (Addgene #42230) with 
BbsI (ThermoFisher Scientific #ER1011). The sequences are the following: 
pX330-MCPH1_bs_up_sense: CACCGCCGCACAAAGCCGTCCGCT  
pX330-MCPH1_bs_up_antisense: AAACAGCGGACGGCTTTGTGCGGC 
pX330-MCPH1_bs_down_sense: CACCGCGCGCCACGTTACTGTTCA  
pX330-MCPH1_bs_down_antisense: AAACTGAACAGTAACGTGGCGCGC 
 10pmol of the gRNAs were mixed in 10x Annealing Buffer (10mM Tris pH8.0, 50mM Sodium 
chloride, 1mM ethylenediamine tetraacetic acid (EDTA) (Addgene)) and annealed using the 
thermocycler, where the temperature was increased up to 95°C for 10min, and slowly decreased until 
25°C, in 30min total. The annealing efficiency was analysed with a 2% agarose gel electrophoresis. The 
gRNAs were then cloned into the pX330 with BbsI following the Quick ligation kit recommended protocol, 
with the single modification of adding only 0.2pmol of gRNA mix. Constructs were Sanger Sequenced. 
 
 Testing of gRNAs – Human embryonic kidney 293 T cells (HEK293T, uncertain origin) were 
seeded at passage 3+12 from a full 60mm dish in a dilution of ¼ cells per well, in a 12-wells plate and 
cultured in Dulbecco's Modified Eagle Medium (DMEM) (1x)+GlutaMaxTM (ThermoFisher Scientific 
#61965026) with 10% HiFBS and 1x P/S. On the following day the medium was changed to 
DMEM+GlutaMax without 1x P/S. Using LipofectamineTM 3000 reagent the cells were transfected with 
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250ng of pX330-gRNA or pX330-EV, 50ng of pCAG-GFP and 200ng of pBluescript, one well per gRNA, 
according to the manufacturer’s recommended protocol. The medium was changed again to 
DMEM+GlutaMax with 10% HiFBS and 1x P/S, 6 hours after. 48 hours after transfection, the cells were 
lysed and the DNA isolated using Quick-DNA Miniprep Plus Kit (Zymo Research), following 
manufacturer’s recommended protocol. A PCR was performed on 25ng of gDNA, using Phusion High-
Fidelity DNA Polymerase, with the primers MCPH1_Prom_F2_primates and 
MCPH1_Prom_R2_greatapes. 
 10% of PCR product was analysed on a 1% agarose gel electrophoresis. Amplicon was purified 
using DNA clean & Concentrator-5 Kit and annealed, following the same protocol. An 8% 
Polyacrylamide gel electrophoresis (PAGE, 8% acrylamide (Bio-Rad #1610146), 1x TAE Buffer (Tris 
base (Sigma-Aldrich #10708976001), acetic acid (Merck Millipore #64-19-7), EDTA (Sigma-Aldrich 
#E5134)), 0.1% ammonium persulfate (APS, Sigma-Aldrich #A3678), 0.00001% 
Tetramethylethylenediamine (TEMED, Sigma-Aldrich #T9281)) was done with 100ng of gDNA. Samples 
migrated at 90V until the loading dye left the gel, then the gel was stained with 0.005% ethidium bromide 
in 1x TAE for 15min on orbital shaker at 50rpm. The gel was imaged using ChemiDocTM MP Imaging 
System (Bio-Rad). 
 
 HDR mediated ZNF675 binding sequence replacement – The chosen gRNA was 
MCPH1_bs_down and a single-stranded DNA (ssDNA) oligo was designed with two homology-arms 
with 30bp each. In between the arms the sequence is from the marmoset genome WUGSC 3.2/calJac3. 




* Indicate phosphothiorate bonds. 
 HEK293T were seeded at passage 3+22 from a full 100mm dish in a dilution of ¼ cells per well, 
in a 12-wells plate and cultured in DMEM+GlutaMax with 10% HiFBS and 1x P/S. Cells were transfected 
on the following day using LipofectamineTM 3000 reagent with 250ng of pX330-MCPH1_bs_down or 
pX330-EV, 50ng of pCAG-GFP and 200ng of pBluescript. On 2 wells with the pX330- MCPH1_bs_down, 
the cells were co-transfected with 10nM and 30nM of MCPH1_ssODN_caljac. 48 hours after 
transfection, the cells were lysed and the DNA isolated using Quick-DNA Miniprep Plus Kit. A PCR was 
performed on 25ng of gDNA, using Phusion High-Fidelity DNA Polymerase, with following primers: 
MCPH1_homJac_Fw1: TGAGGTCTGGAGGTACTCCTG  MCPH1_homJac_Rv1: GGACTTTCGGCGCCTTCC 
MCPH1_homJac_Rv2: CCACTCCAGCCCGACACC 
 Amplicons were analysed on a 1% agarose gel electrophoresis. 
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2.10 ZNF675/ZNF681 KO using CRISPR/Cas9 system 
 Cloning of gRNAs into pX330 vector – The gRNAs were designed upstream (ex1up1 and 
ex1up2) and downstream (ex1down1, ex1down2, ex1down3 and ex1down4) of the first exon of ZNF681. 
The sequences are the following: 
pX330-681_ex1up1_sense: CACCGGGCAAATACCCTGTTGGGT  
pX330-681_ex1up1_antisense: AAACACCCAACAGGGTATTTGCCC 










 The cloning strategy used was the same as previously described for gRNAs. The gRNAs for 
ZNF675 were previously designed upstream and downstream of exon 4 and cloned into a pX330 with 
BbsI. The sequences are the following: 
pX330-675_ex4up2_sense: CACCGTACACTTAATTATGGCCTG  
pX330-675_ex4up2_antisense: AAACCAGGCCATAATTAAGTGTAC 
pX330-675_ex4down1_sense: CACCGATATAAGTGACACATGAGG  
pX330-675_ex4down1_antisense: AAACCCTCATGTGTCACTTATATC 
 
 Testing of gRNAs for ZNF681 – HEK293T were seeded at passage 3+1 at a density of 3.5 x 
105 cells per well, in a 12-wells plate. Cells were cultured in DMEM+GlutaMax with 10% HiFBS and 1x 
P/S. On the following day the medium was changed to DMEM+GlutaMax without 1x P/S. Using 
LipofectamineTM 3000 reagent the cells were transfected with 250ng of pX330-gRNA or pX330-EV, 50ng 
of pCAG-GFP and 200ng of pBluescript, one well per gRNA, according to the manufacturer’s 
recommended protocol. The medium was changed again to DMEM+GlutaMax with 10% HiFBS and 1x 
P/S, 6 hours after. 48 hours after transfection, the cells were lysed and the DNA isolated using Quick-
DNA Miniprep Plus Kit, following manufacturer’s recommended protocol. A PCR was performed on 25ng 
of gDNA from the transfected cells, using LongAmp® Taq DNA Polymerase (New England Biolabs), 
with the following primers: 
681_ex1up_Fw1: ATCCAGGAAGATTTGAATGC  681_ex1down_Rv4: AAAAGCTCCTGGATTGTAGG 
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 10% of PCR product was analysed on a 1% agarose gel electrophoresis. Amplicon was purified 
using DNA clean & Concentrator-5 Kit and annealed, as previously described. An 8% PAGE was done 
with 100ng of gDNA, following the same protocol, and the gel was imaged using ChemiDoc Imager. 
 
 ZNF681 KO and screening – HEK293T cells were seeded at passage 3+14 from a full 60mm 
dish in a dilution of ¼ cells per well in a 12-wells plate and cultured in DMEM+GlutaMax with 10% HiFBS 
and 1x P/S. Cells were transfected, using LipofectamineTM 3000 reagent, with 2x 225ng of pX330-gRNA 
or 450ng of pX330-EV, and 50ng of pCAG-GFP. The gRNA pairs are as follows: 
pX330-681_ex1up1 + pX330-681_ex1down1  pX330-681_ex1up1 + pX330-681_ex1down2 
pX330-681_ex1up1 + pX330-681_ex1down3  pX330-681_ex1up1 + pX330-681_ex1down4 
 48hours after transfection, the cells were lysed and the DNA isolated using Quick-DNA Miniprep 
Plus Kit, following manufacturer’s recommended protocol. A PCR was on 25ng of gDNA, using 
LongAmp® Taq DNA Polymerase with the primer pair 681_ex1up_Fw1/Rv4. Amplicons were analysed 
on a 1% agarose gel electrophoresis. 
 
 ZNF675/ZNF681 KO and screening – HEK293T cells were seeded at passage 9+16 from a full 
60mm dish in a dilution of ¼ cells per well, in a 12-wells plate and cultured in DMEM+GlutaMax with 
10% HiFBS and 1x P/S. Cells were transfected, using LipofectamineTM 3000 reagent, with 2x 225ng of 
pX330-gRNA or 450ng of pX330-EV, and 50ng of pCAG-GFP. The gRNA pairs for ZNF675 and ZNF681 
are as follows: 
pX330-675_ex4down1 + pX330-681_ex1up1   pX330-675_ex4down1 + pX330-681_ex1down3 
pX330-675_ex4down1 + pX330-681_ex1down4   pX330-675_ex4up2 + pX330-681_ex1up1 
 48 hours after transfection, the cells were lysed and the DNA isolated using Quick-DNA Miniprep 
Plus Kit, following manufacturer’s recommended protocol. A PCR was performed on 25ng of gDNA, 
using LongAmp® Taq DNA Polymerase with the primers 681_ex1up_Fw1 and: 
675_ex4up_Rv1: GCATAGTTGGTAAACATTGG  675_ex4down_Rv1: GGGATTACTAGAAATGTTTGTCC 
 Amplicon was analysed on a 1% agarose gel electrophoresis. 
 
 HDR-mediated KO – The gRNA pair 675_ex4down1/681_ex1down3 was chosen and a ssDNA 
oligo was designed with two homology-arms of 30bp each, with the following sequence: 
675-681-dKO-ssDNA: 
A*A*T*G*CAGAATATTACCCTGAACACCCACCTCTCGAGGGATTCGCCCCTGACGACCCTCCCGT*G*G*T*C 
* Indicate phosphothiorate bonds. 
 HEK293T cells were seeded at passage 9+24 from a full 60mm dish in a dilution of ¼ cells per 
well, in a 12-wells plate and cultured in DMEM+GlutaMax with 10% HiFBS and 1x P/S. Cells were 
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transfected using LipofectamineTM 3000 reagent, with 225ng of pX330-675_ex4down1 and pX330-
681_ex1down3 or 450ng of pX330-EV, and 50ng of pCAG-GFP. On 4 wells, the cells were co-
transfected with 2.5nM, 10nM, 30nM and 100nM of 675-681-dKO-ssDNA. 48 hours after transfection, 
the cells were lysed and the DNA isolated using Quick-DNA Miniprep Plus Kit, following manufacturer’s 
recommended protocol. A PCR was on 25ng of gDNA, using LongAmp® Taq DNA Polymerase with the 




2.11 ChIP of human and marmoset ZNF675 
 Cell transfection – HEK293T cells were seeded at passage 3+24 from a full 100mm dish in a ¼ 
dilution of cells per dish, in 8x 100mm dish. Human bone osteosarcoma cells (U2OS, Sigma-Aldrich 
#92022711) were seeded at passage 4+5 in 12x 100mm dishes, at a density of 2.5 x 106 cells per dish. 
Both types of cells were cultured in DMEM+GlutaMax with 10% HiFBS and 1x P/S. On the following day 
the medium was changed to 9ml DMEM+GlutaMax without 1x P/S. The transfection protocol for one 
100mm dish is the following: 
Table 2.03 – Description of protocols followed per transfection of one 100mm dish. The first column 
corresponds to the cell type transfected, the second is the transfection method used with a detailed description in 




Quantity of transfection agent DNA mix (12500ng) 
Incubation 
time 
HEK293T Calcium Phosphate 
500µl of 2x HEPES Buffered 
Saline (HBS) 
50µl of 2.5M CaCl2 + 





25µl in 475µl Opti-MEM 
(ThermoFisher Scientific 
#31985047) 
Opti-MEM to 500 µl 20 min 
 
 The 2x HBS (1.5mM Di-sodium hydrogen phosphate (Merck Millipore #1.06580.1000), 50mM 
HEPES-NaOH pH 7.5, 140mM Sodium chloride) was previously prepared.  
 For the U2OS cells transfection with PEI (Polysciences #23966-1), the DNA mixes per dish 
contained 12500ng pCAG-cZNF675-GFP, 11250ng pCAG-hZNF675-GFP and 1250ng pCAG-GFP + 
8750ng pCAG-EV (pBluescript was added to make the 12500ng). For the HEK293T cells transfection, 
the DNA mixes per dish contained 12500ng of pCAG-cZNF675-GFP and pCAG-hZNF675-GFP. For 
both cell types, the medium was changed to DMEM+GlutaMax with 10% HiFBS and 1x P/S, 6 hours 
after transfection.   
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 Magnetic beads pre-blocking and binding to antibody – DynabeadsTM M-280 Sheep anti-Rabbit 
IgG (Invitrogen/ThermoFisher Scientific #11203D) were used, 50µl per immunoprecipitation (IP). The 
beads were transferred to a 1.5ml tube and 1ml Block Solution (0.5% Bovine Serum Albumin (Sigma-
Aldrich #A2153) in 1x PBS) was added. Beads were washed 2x with 500µ Block Solution, using the 
magnetic stand, and each 50µl of beads was resuspended in 125µl Block Solution. 0.50µl rabbit eGFP-
antibody (ab290, Abcam) was added to each 50µl of beads and incubated minimum 4 hours at 4°C on 
a rotating platform. 
 
 Cell’s crosslinking, lysis and sonication – 48 hours after transfection the medium was removed, 
5ml cold 1x PBS was added and the cells were mechanically detached. The cell suspensions from each 
two dishes were transferred to a 15ml tube, 1ml Crosslinking Buffer (50mM HEPES-NaOH pH 7.5 (VWR 
Chemicals #441476L, Merck Millipore #1064691000), 100mM Sodium chloride (Sigma-Aldrich #S7653) 
1mM EDTA, 0.5mM EGTA (Sigma-Aldrich #E3889) 11% Formaldehyde (Sigma-Aldrich #F8775)) was 
added and the samples incubated for 10min at room temperature on a rocking platform. 500µl 2.5M 
glycine (Sigma-Aldrich #G8898) was added and after 5min incubation at room temperature on a rocking 
platform. Samples were centrifuged 5min at 300xg at 4°C and washed 2x with 10ml cold 1x PBS. The 
pellet of crosslinked cells was resuspended in Lysis Buffer 1 (LB1 – 50mM HEPES-NaOH pH 7.5, 
140mM Sodium chloride, 1mM EDTA, 10% Glycerol (Sigma-Aldrich #15523-1L-R-D), 0.5% NonidetTM 
P 40 Substitute (Sigma-Aldrich #74385), 0.25% Triton X-100 (Merck Millipore #1086031000)) with 
Protease Inhibitor Cocktail (Roche #5892791001), transferred to a 1.5ml tube and incubated for 10min 
at 4°C on a rocking platform. The samples were centrifuged 5min at 300xg at 4°C, resuspended in Lysis 
Buffer 2 (LB2 – 10mM Tris-HCl pH 8 (HCl – Merck Millipore #1.00317.1000), 200mM Sodium chloride, 
1mM EDTA, 0.5mM EGTA) with Protease Inhibitor Cocktail, and incubated for 5min at 4°C on rocking 
platform. The samples were centrifuged again for 5min at 2000xg at 4°C and resuspended in 400µl 
Lysis Buffer 3 (LB3 – 10mM Tris-HCl pH 8, 100mM Sodium chloride, 1mM EDTA, 0.5mM EGTA, 0.1% 
Na-Deoxycholate (Sigma-Aldrich #8220500100), 0.5% N-laurosylsarcosine (Sigma-Aldrich #L5125-
50G)) with Protease Inhibitor Cocktail. The BioruptorTM UCD-200 (Diagenode) was used and the settings 
were as follows: high intensity; 22 cycles of 30s on – 60s off; as the maximum temperature the water 
can reach is 8°C, some water was removed, and ice added every 4 cycles; the samples were spun down 
every 2 cycles. After the sonication, 150µl LB3 and 50µl 10% Triton X-100 were added to the samples, 
they were centrifuged for 10min at maximum speed at 4°C, the supernatant was transferred to a new 
tube, from where 50µl was added to other tube and stored at -20°C as the input control. 
 
 Chromatin Immunoprecipitation – After at least 4 hours incubation of Dynabeads with rabbit 
eGFP-antibody, the mix was washed 3x with 500µl LB3, using the magnetic stand. The antibody coated 
beads were resuspended with 1.5ml 1% Triton X-100 in LB3 and divided over 6x 1.5ml tubes already 
with 250µl 1% Triton X-100 in LB3. 500µl cell lysate was added to the antibody coated beads and 
incubated overnight on a rotator at 4°C. On the following day, the beads were washed 8x with 500µl 
RIPA Buffer (50mM HEPES-NaOH pH 7.5, 500mM Lithium chloride (Merck Millipore #1056790100), 
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1mM EDTA, 1% NP40, 0.7% Na-Deoxycholate) with Protease Inhibitor Cocktail, using the magnetic 
stand, washed 1x with 1ml TBS (50mM Tris-HCl pH 7.6, 150mM Sodium chloride), centrifuged for 3min 
at 950xg at 4°C and any residual TBS Buffer was removed. 200µl Elution Buffer (50mM Tris-HCl pH 8, 
10mM EDTA, 1% Sodium dodecyl sulphate (SDS, Sigma-Aldrich #30970)) was added to the samples, 
and 150µl was added to the previously thawed input controls. Samples were incubated at 65°C overnight 
with rotation (400rpm).  
 DNA isolation and purification – On the next day, the samples were centrifuged for 1min at 
14000rpm, the supernatant transferred to a new 1.5ml tube and 200µl Tris-EDTA (10mM Tris-HCl pH 
8, 1mM EDTA) was added to every sample (including the input controls). 20µl of each sample was 
stored at -20°C. 8µl 1mg/ml RNase Cocktail Enzyme Mix (ThermoFisher Scientific #AM2286) was added 
and incubated for 30min at 37°C. 8µl 10mg/ml Proteinase K (Roche #03115887001) was added and 
incubated for 2 hours at 55°C. To extract the DNA, a phenol:chloroform (Biosolve Chemicals 
#16962344, Rathburn Chemicals #67-66-3) method was performed twice, where 400µl 
phenol:chloroform was added, the tubes agitated for 30s, incubated for 5min on ice, centrifuged for 
15min at 14000rpm at 4°C and the aqueous phase was transferred to a new 1.5ml tube. This method 
was repeated but with chloroform only. The volume was set to exactly 400µl with Tris-EDTA and 16µl 
5M Sodium chloride and 1.5µl 20mg/ml Glycogen were added to the samples. 900µl 100% ethanol was 
also added and after incubating for 45min at -80°C, the samples were centrifuged at 14000rpm at 4°C 
for 45min as well. The supernatant was removed, the DNA pellet washed with 500µl 70% ethanol and 
centrifuged at 14000rpm at 4°C for 10min. All traces of ethanol were removed from the samples and left 
to air-dry briefly. The DNA was resuspended in 20µl water and purified using DNA Clean & Concentrator-
5 Kit. 
  
 ChIP-qPCR – A qPCR was performed on HEK293T DNA, using QuantiTect® SYBR® Green 
PCR (QIAGEN), according to the manufacturer’s recommended protocol. Four sets of primers were 
used, three as positive control and one as negative control, which are the following: 
THE1_F2: CTCCCATCACAGGCCCAGAG   MCPH1_prom_qFw1: GCATAACGGTGCCGAAAGTC 
THE1_R1: CCTTTCAGCCATGGCTGGAG   MCPH1_prom_qRv1: CTGAGCTGAGGATCAGGAAG 
SESN3_prom_qFw1: TCCTTCAGGGCAGTGGTTAG  Control1_chr5_Fw: GTGGCATACCTCTCAACC 
SESN3_prom_qRv1: AAGTTCTTTGAGATCCCTGGA  Control1_chr5_Rv: ATAGCATAGGCCAAGAGC 
 
 Western Blot – The gels for the SDS-PAGE were made: Running gel (10% acrylamide, 0.35M 
Tris-HCl pH 8.8, 0.1% APS, 0.1% SDS, 0.00001% TEMED) and Stacking gel (5% acrylamide, 0.125M 
Tris-HCl pH 6.8, 0.1% APS, 0.1% SDS, 0.00001% TEMED). Samples were prepared in 5% dithiothreitol 
(Sigma-Aldrich #D0632) in 2x Laemmli Sample Buffer (Bio-Rad #1610737). 20µl per sample (from 
U2OS and HEK293T cells) was loaded on the gel and migrated in Running Buffer (1x Tris-Glycine (Bio-
Rad #161-0771), 0.1% SDS) at 100V for 25min, then at 160V for 1h. Blotting on a nitrocellulose 
membrane was performed in Transfer Buffer (1x Tris-Glycine, 20% Methanol (Rathburn Chemicals #67-
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56-1)) at 100V for 2 hours. The membrane was stained with Ponceau S (Sigma-Aldrich #P3504), then 
washed with 1x TBS-T (0.15M Sodium chloride, 0.02M Tris-HCl pH 7.4, 0.001% Tween-20 (Sigma-
Aldrich #P9416)). The membrane was blocked in 5% Milk powder in 1x TBS-T for 1hour on orbital shaker 
and washed once with 1x TBS-T. Primary antibody rabbit anti-GFP (Abcam ab290) (1:2500) was 
incubated in 1x TBS-T overnight at 4°C on rotator. The membrane was rinsed once and washed 3x with 
1x TBS-T for 15min each on orbital shaker. Secondary antibody goat anti-rabbit-HRP (ThermoFisher 
Scientific #65-6120) (1:25000) was incubated in 1x TBS-T, for 1hour on orbital shaker. Membranes were 
incubated with Supersignal westdura ECL substrate (ThermoFisher Scientific #34075), according to the 









3.1 Divergent evolution of ZNF675 and ZNF681  
To investigate the evolutionary history of the ZNF675 and ZNF681, a predictive DNA recognition 
tool was used. The analysed ZNF675 protein sequences are from human, crab-eating macaque and 
marmoset, and the ZNF681 sequence from human and crab-eating macaque. Since the marmoset 
ZNF675 is the oldest, it is certainly the most similar to the first ZNF675. It is composed of 4 initial 
degenerate and 19 functional ZNF motifs (Figure 3.01), making it the largest. Regarding the differences 
between ZNF675 and ZNF681 of crab-eating macaque and human, the ZNF675 of the OWM’s ancestor 
was recreated. This ZNF675 got a nonsense mutation, preventing the last 6 ZNF motifs from being 
translated. Then a duplication event happened, giving rise to ZNF681. Finally, a deletion of 2 ZNF motifs 
occurred in the ZNF675, creating a protein with only 11 functional ZNF motifs. This novel ZNF675 is 
significantly different from the marmoset ZNF675, since the DNA sequence it recognizes is also different 
and shorter (considering that every ZNF motif binds to DNA). ZNF675 is present from the crab-eating 
macaque onwards, with a high sequence conservation between species. Even though ZNF681 
remained with the same number of ZNF motifs, 2 of which degenerated, the DNA motifs they recognize 
changed considerably among the two species. 
 
Figure 3.01 – Structural changes of ZNF675 and ZNF681 throughout primate evolution. ZNF motifs 
characterized as degenerate are represented in grey, whereas functional are in different colours, meaning different 
DNA motifs which they recognize. The shady regions are untranslated ZNF motifs. The KRAB domain is 
represented as the blue box. 
 
 
3.2 Modifications to ZNF675 binding site in THE1B-int elements 
To investigate the ZNF675 binding difference across the THE1B-int elements, 15 sequences 
were chosen, based on high sequence similarity score, and aligned with Multiple Sequence Alignment 
MUSCLE on UGENE. When comparing both THE1B-int bound and unbound elements, there is a clear 
decrease in sequence conservation in the centre region (Figure 3.02), which coincides with the ZNF675 
binding site. Within the binding site, specifically in the stretch of adenines, there is frequently an indel or 













Figure 3.02 – THE1B-int elements. (a) THE1B-int elements bound by ZNF675, with its binding site marked in the 
centre region. (b) THE1B-int elements not bound by ZNF675. Every element represented here has a length of 
~1600bp and a similarity score higher than 12400.  
 
 
3.3 ZNF675 binds to promoters of gene related to development and neuronal processes 
Through the analysis of combined ChIP-seq data (GSM2466628, GSM1407624), a list of genes 
whose promoters are bound by ZNF675 was created. Out of the 351 genes, 25% are involved in 
development and neuronal processes, for instance involved in cell signalling, metabolism or associated 
with neuronal diseases. In 54% of the genes, the ZNF675 binding site coincides with the binding of 
transcription factors and RNA Polymerase II. Moreover, in 48% of the cases the ZNF675 binds to a 
retrotransposon nearby the gene, and, in 7% ZNF675 binds to the transcribed region of a long non-
coding RNA. 
Representation of the selected genes, with the correspondent MACS peak from both ChIP-seq 
data sets and the gene function, is present in table 3.01. Even though most of the genes are present in 
both data sets, some are only present in one. The MACS peak is different when comparing both data 
sets, since their method is also different. 
 
Table 3.01 – Gene promoters bound by ZNF675. First column corresponds to genes whose promoters are bound 
by ZNF675, the second is the chromosome where it locates. Third and fourth columns are the peak signal from the 
ChIP-seq data GSM2466628 and GSM1407624, respectively. The fifth column corresponds to the gene function. 
Gene Chromosome 
Peak signal from 
GSM2466628 
Peak Signal from 
GSM1407624 
Function 
OAT 10 211 51 
Key enzyme glutamate/GABA 
synthesis 
ZNF778 16 194 41 





TCF25 16 174 – 
Transcription factor important in 
embryonic development 
WNT5A 3 168 – Wnt signalling 
CRY1 12 154 83 Circadian clock gene regulation 
CHST10 2 147 – 
Indirectly involved in synapse plasticity 
of the hippocampus 
HES1 3 126 20 NOTCH signalling 
TXLNA 1 117 47 Exocytosis of neuroendocrine cells 
MEGF10 5 108 13 Schizophrenia, myopathy 
TEX28 X 107 50 Encephalopathy and mental retardation  
TCTN3 10 100 73 Cilium biogenesis, Hedgehog signalling 
CHMP1A 16 86 12 Vesicle transport, brain development 
MCPH1 8 43 11 Regulation brain size 
SESN3 11 22 23 Master regulator of pro-epileptic genes 
NEUROG3 10 – 21 Neurogenesis 
 
 
3.4 HES1 expression is up-regulated after induced neuronal differentiation 
 HES1 expression levels are known to change upon RA treatment in neuroblastoma cells, which 
induces differentiation (Jögi, Persson, Grynfeld, Påhlman, & Axelson, 2002). SK-N-SH cells (Figure 
3.03a) were treated with 10µM RA, the RNA was extracted, and a one-step RT-PCR was performed. 
The amplicons were analysed on gel (Figure 3.03b), relative density of which was assessed. Comparing 
to the expression of HES1 on T0, which is set to 1, the fold-change in expression levels is greater after 
24 hours of treatment (6-fold) than after 2 hours (3-fold) (Figure 3.03c).  








Figure 3.03 – HES1 expression levels change after Retinoic Acid treatment. (a) Heterogeneous SK-N-SH cells, 
with different subtypes present. Magnification of 10x. (b) 1% agarose gel electrophoresis of HES1 amplicons from 
a one-step RT-PCR, after cells treatment with RA and ethanol, as control. DNA ladder used is GeneRuler™ Low 
Range (#SM1193, Thermo Scientific). (c) Fold-change of HES1 relative expression after RA treatment, analysed 

































3.5 Significant changes in the binding site of ZNF675 in MCPH1 and SESN3 promoters in 
primates 
 To assess the ZNF675 binding site location on MCPH1, ChIP-seq data of ZNF675 
(GSM1407624, GSM2466628) was analysed (Figure 3.04, top). In the MCPH1 gene, ZNF675 binds in 
the promoter region, 360bp from the TSS, within the long non-coding RNA LOC100287015. Sequence 
from the centre region of the ChIP peak, containing the predicted ZNF675 binding site, was analysed in 
several primate species, selected from the UCSC Genome Brower. Sequence conservation was 
assessed using the Multiple Sequence Alignment MUSCLE on UGENE. Clear modifications occurred 
in the binding site of ZNF675, specifically in the LCA of apes and humans (Figure 3.04, bottom). Both 
groups of primates have a 3-4 nucleotides deletion in the centre of the ZNF675 binding site, comparing 
to the NWMs. Regarding the OWM, a 1-2 nucleotides insertion and substitutions occurred in the same 
region. Though, considering the sequence similarity of apes and NWMs, mutations probably took place 
in the ancestor of OWM, being a family-specific change. There are some species-specific mutations 
across all primates, which are mostly substitutions. 
 
Figure 3.04 – MCPH1 promoter region. Visualization of ZNF675 ChIP signal on the UCSC Genome Browser, 
localized within a long non-coding RNA LOC100287015 (top). Zoomed in region of MCPH1 promoter sequences 
from NWM until Humans, with 67bp in length (bottom).  
  
 The same analysis previously described for MCPH1 was reconducted for SESN3. The ZNF675 
binding site location on SESN3 was analysed (Figure 3.05, top). In the SESN3 gene, the binding site of 
ZNF675 is in the promoter region of the standard gene, 590bp away from the TSS. Although if the gene 
starts with the alternative TSS, the binding site is localized within the first intron, 870bp away from the 
start of the first exon. In this case, the first exon of the standard gene is not transcribed. Sequence 
conservation was assessed using the Multiple Sequence Alignment MUSCLE on UGENE. When 




ZNF675 binding site (Figure 3.05, bottom). From thereafter the sequence remained highly conserved, 
although there are species-specific substitutions, mostly outside of the binding site. A more drastic 
change happened in the ancestral version of the NWM, where a 4 nucleotides deletion occurred, being 
probably a family-specific mutation. There are several substitutions across all species analysed, the 
majority present in the basal primates’ promoter region. 
 
Figure 3.05 – SESN3 promoter region. Visualization of ZNF675 ChIP signal on the UCSC Genome Browser, 
localized in an intron of SESN3 gene with an alternative TSS (top). Zoomed in region of SESN3 promoter sequences 
from basal primates until Humans, with 67bp in length (bottom).  
 
 
3.6 Differential effect of ZNF675 binding on MCPH1 and SESN3 promoters throughout 
evolution 
 To investigate the binding affinity of both ZNF675 from human and marmoset on the MCPH1 
and SESN3 promoter regions, Luciferase Reporter Assays were performed. MSTA-Luciferase 
constructs were used as positive control in both assays (Figure 3.06, top). The hZNF675 repressed the 
reporter expression by 89%, although the cZNF675 did not have any effect (Figure 3.06a, bottom). On 
the human MCPH1 construct, though hZNF675 did not repress the reporter expression, the cZNF675 
repressed it by 13%. In the marmoset MCPH1 construct, both human and marmoset ZNF675 influenced 
the reporter expression, repressing it by 11% and 8%, respectively. When comparing the repressive 
effect of hZNF675 on both human and marmoset MCPH1 constructs, there is a change in binding 
affinity, resulting in 13% less expression in the marmoset MCPH1. However, the repressive effect of 




 On the human SESN3 construct (Figure 3.06b, bottom) the hZNF675 had a strong effect, 
repressing it by 48%. On the contrary, cZNF675 had no influence on the reporter expression. On the 
marmoset SESN3, neither of human and marmoset ZNF675 had an effect.  
a.           b.  
 
Figure 3.06 – Luciferase Reporter Assays on MCPH1 and SESN3, in the presence of hZNF675 and cZNF675. 
(a-b) Schematic of SV40-Luciferase constructs: EV, (3x) 100bp of MSTA, (3x) 200bp of hMCPH1, cMCPH1, 
hSESN3 and cSESN3 (top) and correspondent Luciferase Reporter Activity after transfection of the constructs in 
mESC (bottom). Each graph is the result of three independent experiments with n=6. Empty vector is set to 1 for 
comparison. Statistical analysis: Two-way repeated measures ANOVA; *P<0.001; error bars are s.e.m.  
 
 
3.7 Isolation of MCPH1 promoter region from different primate species 
 To enable the analysis of the ZNF675 binding affinity to the MCPH1 promoter from different 
primates, a region of around 1200bp was amplified from gDNA of 7 species: human, chimpanzee, gorilla, 
orangutan, gibbon, rhesus macaque and baboon (Figure 3.07a). To be able to clone these sequences 
in a vector, the DNA was extracted and amplified with primers with restriction sites (Figure 3.07b).  
 The marmoset region, though, could not be amplified. A gradient PCR was performed with 
annealing temperatures ranging from 58°C to 63.9°C and the amplicons were analysed in a 1% agarose 
gel electrophoresis (Figure 3.07c). The two amplicons present in every amplification were extracted and 
Sanger sequenced. The result of which identified the DNA as being bacterial. A new approach was 
taken, and new primers designed: F4, R6 and R7. The F4 and R7 are the reverse and complement of 
each other, amplifying two sequences that overlap in 22bp. The primer pair F3/R7 would amplify a region 
of 1010bp, whilst the primer pairs F4/R6 and F4/R5 would amplify regions of 306bp and 126bp, 
respectively. In a second PCR, the overlapping region from the products of the amplification with the 
F3/R7 primer pair and F4/R5 or F4/R6 would hybridize and function as a primer for the amplification of 
the whole region. However, the amplification of the two sequences was unsuccessful, since there are 

























































































Figure 3.07 – MCPH1 promoter region from several primate species analysed by 1% agarose gel 
electrophoresis. (a) MCPH1 promoter amplicons. (b) MCPH1 promoter amplicons with restriction sites on both 
ends. (c) Unspecific products of amplification of marmoset MCPH1 promoter with F3/R5 primers, differing on the 
PCR annealing temperature (indicated in the image). (d) Unspecific products of amplification of marmoset MCPH1 
promoter with different primer pairs: F3/R7, F4/R6 and F4/R5. In every 1% agarose gel electrophoresis the DNA 
ladders used were GeneRuler™ High Range (#SM1353, Thermo Scientific) and GeneRuler™ Low Range. 
 
 
3.8 ZNF675 binding site of the marmoset MCPH1 promoter in a human context 
 The CRISPR/Cas9 system was used as a genome editing tool, by inducing the replacement of 
the ZNF675 binding site on the human MCPH1 promoter by the marmoset, through HDR. The gRNAs 
that target the ZNF675 binding site were designed (Figure 3.08a), cloned and transfected in HEK293T 
cells (Figure 3.08b). The transfection was verified by GFP-positive cells, visible in the cytoplasm. If the 
gRNA introduced a double stranded break on the DNA, it can form heteroduplexes after being randomly 
annealed. These DNA fragments will migrate slowly in the gel due to their structure. According to this, 
by the analysis of the PAGE (Figure 3.08c), both gRNAs are working correctly, though 


















Figure 3.08 – Testing of gRNAs that target the ZNF675 binding site on the MCPH1 promoter. (a) Visualization 
of the gRNAs pX330-MCPH1_bs_up and pX330-MCPH1_bs_down on the UCSC Genome Browser. Grey bar is 
the predicted ZNF675 binding site. (b) Example of transfected HEK293T cells with gRNAs. Magnification of 10x. (c) 
8% PAGE of MCPH1 promoter region after cells’ transfection of pX330-MCPH1_bs_up, pX330-MCPH1_bs_down 
and pX330-EV. The DNA ladders used were GeneRuler™ High and Low Range. 
 
 The ssDNA oligo used, MCPH1_ssODN_caljac, comprises of two 30bp homology-arms which 
are complementary to the promoter sequence of human, whilst from the introduced double-stranded 
break until the end of the ZNF675 binding site the sequence is from the marmoset (Figure 3.09a). The 
ssDNA oligo was co-transfected with the gRNA MCPH1_bs_down in HEK293T cells (Figure 3.09b), 
which was verified with GFP-positive cells. Cells transfected with the EV and the gRNA have a higher 
number of GFP-positive cells, whereas in the co-transfection of 10nM and 30nM of ssDNA oligo, it 
appears to be slightly lower. To analyse if the genome editing was successful, the replaced region was 
amplified, with one primer within the marmoset region and another in the human MCPH1 promoter. The 
amplicon was analysed on gel (Figure 3.09c). Even though there are unspecific products from the PCR, 
there is one amplicon, with the expected size of 260bp, that is only present in the cells co-transfected 























Figure 3.09 – Replacement of ZNF675 binding site on the MCPH1 promoter by the marmoset. (a) Visualization 
of the gRNA pX330-MCPH1_bs_down and the oligo MCPH1_ssODN_caljac on UCSC Genome Browser. Arrow 
indicates the induced double-stranded break. (b) HEK293T cells transfected with pX330-EV, pX330-
MCPH1_bs_down and co-transfected with the gRNA and MCPH1_ssODN_caljac with different concentrations: 
10nM and 30nM. Magnification of 10x. (c) 1% agarose gel electrophoresis of replaced region from HEK293T cells 
transfected with pX330-EV and co-transfected with pX330-MCPH1_bs_down and 30nM of MCPH1_ssODN_caljac. 
PCR was done with the primers F1/R1 and F1/R2. Arrow points to the band of 260bp. The DNA ladder used was 
GeneRuler™ Low Range. 
 
 
3.9 ZNF675/ZNF681 KO using CRISPR/Cas9 
 In order to get a ZNF675/ZNF681-/- cell line, a working CRISPR/Cas9 system was created. 
gRNAs that target exon 1 of ZNF681 were designed (Figure 3.10a), cloned and tested in HEK293T cells 
(Figure 3.10b). The transfection was verified with GFP-positive cells. By the analysis of the PAGE 
(Figure 3.10c), all gRNAs work correctly, except for 681_ex1up2. Finally, HEK293T cells were 




and 681_ex1down4. gDNA was amplified and analysed on gel (Figure 3.10d). Every gRNA combination 
worked, inducing a deletion of ZNF681, which can be verified by the lowest bands present on the gel. 
 
a. 














Figure 3.10 – Testing of gRNAs that target exon 1 of ZNF681. (a) gRNAs visualized on UCSC Genome Browser. 
(b) Example of transfected HEK293T cells with a gRNA with 10x of magnification. (c) 8% PAGE of ZNF681 region 
after HEK293T transfection with the gRNAs: pX330-681_ex1up1, pX330-681_ex1up2, pX330-681_ex1down1, 
pX330-681_ex1down2, pX330-681_ex1down3, pX330-681_ex1down4 and pX330-EV. (d) 1% agarose gel 
electrophoresis of ZNF681 region after transfection of the gRNA pX330-681_ex1up1 paired with pX330-
681_ex1down1, pX330-681_ex1down2, pX330-681_ex1down3 and pX330-681_ex1down4, and transfection of 
pX330-EV. The DNA ladder used was GeneRuler™ Low Range. 
 
 To induce a deletion of both ZNF675 and ZNF681 genes, the gRNAs 681_ex1up1, 
681_ex1down3 and 681_ex1down4 were paired with the previously tested gRNAs for ZNF675, 
675_ex4down1 and 675_ex4up2 (Figure 3.11a). HEK293T were transfected with combinations of the 
gRNAs (Figure 3.11b), which was verified with GFP-positive cells. To assess the deletion induced by 




3.11c). All the ZNF681 gRNAs paired with the gRNA 675_ex4down1 were successful. The pair 
675_ex4down1/681_ex1down3 was the most efficient, which can be verified by the intensity of the band 
in the fourth lane. The 675_ex4up2/681_ex1up1 pair did not work. 
a. 
    






Figure 3.11 – ZNF675/ZNF681 KO using CRISPR/Cas9 system. (a) Visualization of gRNAs for ZNF675 and 
ZNF681 on UCSC Genome Browser. (b) Example of transfected HEK293T cells with a gRNA pair. Magnification of 
10x. (c) 1% agarose gel electrophoresis of ZNF675-ZNF681 region after HEK293T transfection of pX330-
675_ex4down1/pX330-681_ex1up1, pX330-675_ex4down1/pX330-681_ex1down3, pX330-
675_ex4down1/pX330-681_ex1down4, pX330-675_ex4up2/pX330-681_ex1up1 and pX330-EV. The DNA ladders 
used were GeneRuler™ High and Low Range. 
  
 To improve the efficiency of the deletion, an approach using HDR was adopted. The ssDNA 
oligo used, 675-681-dKO-ssDNA, comprises of two 30bp homology-arms which are complementary to 
the sequence that remains after deletion, on both ends (Figure 3.12a). The ssDNA oligo was co-
transfected with the gRNA pair 675_ex4down1/pX330-681_ex1down3 in HEK293T cells (Figure 3.12b). 
The transfection was verified with GFP-positive cells, which appears to be in higher number in the 
conditions with EV, gRNA pair and in the co-transfection of the gRNA pair and 2.5nM and 10nM of 
ssDNA oligo. On the contrary, in the conditions with 30nM and 100nM of ssDNA oligo, the number of 
GFP-positive cells is lower. To assess the deletion efficiency, the ZNF675-ZNF681 region was amplified 
and analysed on gel (Figure 3.12c). The efficiency of the deletion was greater in the transfection with 
the gRNA pair only, however, the co-transfection of gRNA pair and 10nM and 30nM of ssDNA oligo 
appears to be reasonable. Conditions with 2.5nM and 100nM of ssDNA oligo had the lowest efficiency. 

























Figure 3.12 – HDR-mediated ZNF675/ZNF681 KO using CRISPR/Cas9 system. (a) Visualization of the gRNA 
pair pX330-675_ex4down1/pX330-681_ex1down3 and the oligo 675-681-dKO-ssDNA on UCSC Genome Browser. 
(b) HEK293T cells transfected with the pX330-EV and 675_ex4down1/pX330-681_ex1down3, and co-transfected 
with the gRNA pair and the 675-681-dKO-ssDNA with different concentrations: 2.5nM, 10nM, 30nM and 100nM. 
Magnification of 10x. (c) 1% agarose gel electrophoresis of ZNF675-ZNF681 region from the transfected cells. The 
DNA ladders used were GeneRuler™ High and Low Range. 
 
 
3.10 ChIP of human and marmoset ZNF675 
 The binding site of human ZNF675 has already been described, by analysing ChIP-seq data 
(GSM1407624, GSM2466628). However, there is no information regarding the marmoset ZNF675. A 
ChIP was performed, using HEK293T cells transfected with the previously cloned pCAG-hZNF675-GFP 























Human 1 Human 2 Marmoset 1 Marmoset 2
analysed by qPCR (Figure 3.13b). There is an enrichment of THE1 elements, MCPH1 and SESN3 
promoter regions in the IP for hZNF675, comparing to the control. On the contrary, the IP for cZNF675 
showed no substantial enrichment for either of the analysed regions. These results are supported by 
the western blot analysis (Figure 3.13c), since the cZNF675, with a size of 122.96 kDa, is absent in the 
IP samples. The hZNF675, with a size of 94.08 kDa, is present in the IP samples, though with a very 
faint signal. Moreover, there was degradation of both ZNF675 proteins, since there is intense signal for 
GFP, with a size of 25kDa. The signal at 55kDa in the IP samples is most likely the eGFP-antibody used 


















Figure 3.13 – ChIP of human and marmoset ZNF675 on HEK293T. (a) HEK293T cells transfected with pCAG-
hZNF675-GFP and pCAG-cZNF675-GFP. Magnification of 10x. (b) qPCR with primers for THE1 elements, MCPH1 
and SESN3 promoter regions, and a non-coding region on Chromosome 5 as negative control. (c) Immunoblot of 
IP DNA from cells transfected with pCAG-hZNF675-GFP and pCAG-cZNF675-GFP (2 samples each), 






 In order to improve the ChIP, it was performed following the same protocol in U2OS cells 
transfected with pCAG-GFP, pCAG-hZNF675-GFP and pCAG-cZNF675-GFP (Figure 3.14a). The 
transfection was verified by GFP-positive cells. ChIP samples were analysed by western blot (Figure 
3.14b), which shows the same results as previously, though without protein degradation. While low 
levels of hZNF675 are detected in the IP, the cZNF675 remains undetectable. Therefore, these samples 

















Figure 3.14 – ChIP of human and marmoset ZNF675 on U2OS cells. (a) U2OS cells transfected with pCAG-
GFP, pCAG-hZNF675-GFP and pCAG-cZNF675-GFP. Magnification of 10x. (b) Immunoblot of IP DNA from cells 
transfected with pCAG-GFP, pCAG-hZNF675-GFP and pCAG-cZNF675-GFP (2 samples each), correspondent 








 The arms race between transposable elements and KZNF proteins have been shaping the 
genome throughout primate evolution, affecting mostly regulatory networks (Imbeault et al., 2017; 
Jacobs et al., 2014; Najafabadi et al., 2015). In fact, both TEs and KZNF proteins have been described 
to be involved in important processes, including development. The study of developmental mechanisms 
can shed light on evolutionary modifications in primates. Interestingly, within the transcription factors 
that are differentially expressed in the human brain, comparing to that of the chimpanzee, KZNF proteins 
are over-represented and have been associated, at least in part, to its size and complexity (Nowick et 
al., 2009). 
 ZNF675 is expressed in the brain, being associated with multiple neurological disorders. It arose 
in the LCA of NWM and OWM. It got a nonsense mutation followed by a duplication event in the LCA of 
OWM and apes, giving rise to ZNF681. Both new KZNF proteins are significantly different from the 
marmoset ZNF675, recognizing new DNA sequences due to modifications in several ZNF motifs (Figure 
3.01). However, ZNF675 protein structure remained conserved from the OWM onwards, implying that 
crab-eating macaque and human ZNF675 have the same DNA binding site. On the contrary, ZNF681 
underwent some changes in the ZNF domain. When comparing the crab-eating macaque and the 
human ZNF681, there are two ZNF motifs that recognize different DNA sequences. These two proteins 
have acquired new DNA binding sites, which might imply new regulatory properties.  
 ZNF675 represses THE1 and MST elements, by binding to the internal part of the 
retrotransposons. The drastic changes in the ZNF675 protein structure happened in the LCA of OWM 
and apes, which was after the great expansion of THE1 and MST elements, in the LCA of NWM and 
OWM, around 35 Mya (Lodewijk et al., unpublished). In fact, the marmoset ZNF675 has shown no 
repressive effect on an MSTA element, member of the MST family (Figure 3.06, bottom). The human 
ZNF675 repressed the MSTA element by 89% in the reporter assay (Figure 3.06, bottom). According to 
the model described by Jacobs and colleagues, since the marmoset ZNF675 did not have affinity for 
these elements when they were active, a new ZNF675 arose in order to silence them. In the NWMs, 
even though THE1 and MST elements were not repressed by the marmoset ZNF675, other KZNF 
proteins are found to bind in the LTR region, which might have a repressive effect. Moreover, ZNF586 
emerged in the LCA of NWM and OWM and it binds to these elements, in the internal part (Lodewijk et 
al., unpublished). However, the binding affinity may have not been strong enough, therefore the THE1 
and MST elements remained active and a new repressor was required.  
 THE1B elements, members of the THE1 family, are repressed by ZNF675, though there are 
some of these elements that the ZNF675 does not bind to. The main difference between them is the 
region of the predicted ZNF675 binding site, where several changes have occurred (Figure 3.02). Since 
KZNF proteins bind to consecutive DNA base pairs (Persikov & Singh, 2014), changes in these DNA 
motifs, such as indels, will affect the KZNF protein binding capacity. THE1 elements, together with MST 




transposing is no longer needed. However, by binding to these retrotransposons, the ZNF675 repressive 
effect might have a function in the establishment of a heterochromatin state in important regions of the 
genome. 
 KZNFs are known to bind to gene promoters, which is thought to be a collateral consequence 
of the arms race against TEs. ZNF675 binds to genes that are involved in cell cycle, signalling, 
metabolism and also some related to disease (Table 3.01). Of these genes, 25% are associated with 
development and neuronal processes, including HES1, MCPH1 and SESN3. The binding site of 
ZNF675, in 54% of the cases, is in the same region as that of transcription factors. This means that the 
ZNF675 might indeed be involved in the regulation of gene expression. The repression mechanism of 
KZNF proteins, through the recruitment of KAP1, is most likely similar when there is also binding of 
another TFs in the same region. However, the repression effect might change since there is probably 
competition with the other factors. Furthermore, ZNF675 binds to a TE in 48% of the cases, in agreement 
with the hypothesis that these elements function as regulatory platforms to regulate nearby gene 
expression (Imbeault et al., 2017; Najafabadi et al., 2015). In the NWM, when these elements inserted 
themselves in promoter regions, the gene expression levels might have changed because of its 
enhancer/repressive potential or the different binding of TFs. When the ZNF675 arose in LCA of OWM 
and apes, it started to repress these elements, thus changing the genes’ expression once more. This 
regulatory modifications to important genes related to development or neuronal processes might have 
influenced the evolution of primates. 
 Conservation of the ZNF675 target genes across primate species is important in the study of 
the ZNF675 regulatory role during evolution. HES1, a gene involved in brain development, has remained 
conserved throughout primates’ lineage, and so has its promoter region (data not shown). However, it 
is known to be up-regulated in neuroblastoma cells, after induced differentiation with RA (Jögi et al., 
2002). The same experiment was performed in a neuroblastoma cell line (SK-N-SH), confirming the up-
regulation of HES1 upon RA treatment (Figure 3.03). This experiment’s goal was to compare the 
difference of HES1 expression in ZNF675 KO cell lines, with and without induction via RA. Since the 
ZNF675-/- cells were in fact heterozygotic and that the SK-N-SH cells were composed of two different 
cell subtypes, the experiment was not concluded. 
 MCPH1, also a gene involved in brain development, on the contrary, has been under positive 
selection during primates’ evolution. Changes in its protein-coding region occurred mainly in the LCA of 
OWMs and apes, and continued to be positively selected in the humans’ lineage (Evans et al., 2004; Y. 
Q. Wang & Su, 2004). The MCPH1 promoter has been overall conserved throughout primates’ evolution, 
since the LCA of NWM and OWM. The basal primates’ promoter region, however, is extremely different 
from that of the evolutionarily later species (Figure S1). For that reason, their sequence was not part of 
the analysis. ZNF675 binding site on the MCPH1 promoter is one of the regions that underwent more 
modifications during primates’ evolution (Figure 3.04, bottom). Specifically, apes and humans have a 
deletion of 3-4 nucleotides, when comparing to the sequence of NWMs. This change could have had a 




promoter of OWM has also undergone modifications, which coincides with the structural changes of 
ZNF675. 
 The binding of human ZNF675 to the human MCPH1 promoter region was shown to have no 
effect in the reporter expression (Figure 3.06a, bottom). On the contrary, in the marmoset MCPH1 
promoter region, both human and marmoset ZNF675 had a similar effect on the reporter, repressing it 
by 11% and 8%, respectively. Together with the fact that the marmoset ZNF675 had the same effect in 
both promoters, changes in the ZNF675 binding site might have resulted in the promoter of MCPH1 
evading ZNF675 repression. However, the difference in repression can be due to changes in the 
ZNF675 binding site and/or in its structure. Therefore, it is necessary to do a reporter assay with the 
ZNF675 of crab-eating macaque and its MCPH1 promoter. Since crab-eating macaques share the same 
form of ZNF675 as humans, the only variable will be the changes in the MCPH1 promoter. Difference 
in binding will then clarify the cause for the evolutionary derepression of MCPH1. Since there is no 
accurate way of knowing the ancestral version of the MCPH1 promoter, this analysis was done 
considering the marmoset MCPH1 promoter as being the closest to that of the LCA of NWM and OWM. 
However, changes in the ZNF675 binding site might have happened in the NWM lineage, after the split.  
 Even though the ZNF675 was shown to bind to the MCPH1 promoter, it does not seem to have 
a repressive effect on gene expression. The ZNF675 might not have a regulatory function on the MCPH1 
gene in humans, though it once had in NWMs, which shows the evolutionary derepression of this 
neurodevelopmental gene. However, since the luciferase reporter assays are performed in mESC, the 
results cannot be directly translated to the human context. Since the ZNF675 acts in a cell-type specific 
manner (Imbeault et al., 2017), it might be differentially expressed in neuronal cells, thus repressing the 
MCPH1 expression. Thereby, this repressive effect cannot be accurately assessed in mESCs. 
 MCPH1 is an important gene in brain development, because of its role in the regulation of brain 
size. It controls neurogenesis, by regulating the G2/M checkpoint, in order to maintain the pool of 
neuroprogenitors (Liu et al., 2016). In cases of MCPH1 deficiency, there is a delay in cell division. During 
neurogenesis, this delay, even if subtle, can have a strong impact on the final quantity of neurons, 
causing microcephaly (Arroyo et al., 2017). In agreement with this, a difference of 8% in MCPH1 
expression could have had a big effect on brain size during primates’ evolution. To further analyse the 
ZNF675 binding affinity in different primates, MCPH1 promoter region of 1200bp was isolated (Figure 
3.07). However, further work still must be done since the isolation of the marmoset MCPH1 sequence 
was unsuccessful. 
 The genome editing CRISPR/Cas9 system has been used to modify the genome with high 
specificity (Ran et al., 2013). This system was chosen as a tool to replace the ZNF675 binding site in 
the human MCPH1 promoter by the marmoset. After a double-stranded break in the DNA, the 
mammalian cell repairs the damage through non-homologous end-joining (NHEJ) or homology-directed 
repair. The latter uses a homologous DNA sequence to repair the damage faithfully, this can be a sister 
chromatid or even a ssDNA oligo. Therefore, an exogenous ssDNA oligo with the marmoset binding site 
for ZNF675 flanked by human sequences was used as template for the HDR. The MCPH1 promoter 




modified region (Figure 3.09). If this strategy is successful, regulation of the MCPH1 by the ZNF675 can 
be studied endogenously, and reporter assays can be performed, for instance to confirm the ZNF675 
binding site.  
 SESN3, though not a gene involved in brain development, has been associated with epilepsy, 
being described as the regulator of proconvulsant genes (Johnson et al., 2015). The conservation of 
this gene has not yet been studied, however the promoter region conservation was analysed here. 
Similarly to the MCPH1 promoter, the overall region has been conserved throughout primates’ evolution. 
Although, when comparing to the sequence of basal primates, changes in the ZNF675 binding site are 
mainly present in the NWMs, being highly conserved in the lineage from OWMs to humans (Figure 3.05, 
bottom). The pattern of changes of the ZNF675 binding site coincides with its structural changes. This 
is initial evidence for a stabilization of the regulatory function of ZNF675 on the SESN3 gene. 
 The human ZNF675 showed a strong effect on the human SESN3 promoter, repressing the 
reporter expression by 48% (Figure 3.06b, bottom). On the contrary, the human ZNF675 had no effect 
on the marmoset promoter, neither the marmoset ZNF675 on the human nor the marmoset SESN3. 
This means that structural changes of the ZNF675 had no influence in its binding capacity, in this case. 
Only changes in the binding site of ZNF675 increased the binding affinity of this KZNF for the SESN3 
promoter. The repression level of SESN3 was maintained throughout primates’ evolution, since there 
were no other modifications to the ZNF675 binding site, besides those in the LCA of OWMs and apes. 
 ZNF675 has been associated with several neurological diseases. Even though epilepsy has not 
been described as one, there is a reported patient (DECIPHER ID: 289120), with a deletion of both 
ZNF675 and ZNF681 proteins, who has seizures. Since ZNF675 is thought to strongly repress SESN3 
expression, derepression of this gene may imply an up-regulation of proconvulsant genes. This might, 
therefore, be one of the causes for the reported seizures. 
 The analysis of clinical data from DECIPHER has revealed that whenever there is a deletion or 
duplication of ZNF675, the ZNF681 is also included. For this reason, in order to study the effect on the 
transcriptome in case of deletion, a ZNF675/ZNF681 KO cell line has to be created. In this way, changes 
in gene expression will shed light on the regulatory function of both ZNF675 and ZNF681, that are 
compromised in a disease background. The CRISPR/Cas9 system was chosen, thereby gRNAs were 
designed for ZNF675, targeting exon 1, and for ZNF681, targeting exon 4, which codes for the ZNF 
domain (Figure 3.11). The ZNF675/ZNF681 KO was successful. HDR-mediated genome editing, 
through exogenous ssDNA oligos, has been described to improve the efficiency of the genome editing 
(Chu et al., 2015; Schiel, Chou, Mayer, Anderson, & van Brabant Smith, 2016). This approach was 
tested and although the efficiency of the deletion seemed not to have improved (Figure 3.12), to exclude 
an effect of the oligo the necessary controls still have to be conducted. Since the size of the deletion is 
107kb, a high deletion efficiency might be reached with the CRISPR/Cas9 system alone. In fact, this 
approach was successful in inducing a much bigger deletion of 725kb in human induced pluripotent 




 Current information regarding the human ZNF675 is enough to analyse its binding throughout 
the genome. The evolutionary history, however, still needs to be completed. ChIP-seq of the marmoset 
ZNF675 is necessary to reveal if or which retrotransposons, or even gene promoters, it binds to. The 
ChIP was performed in HEK293T, for both marmoset and human ZNF675, the latter used as control. 
There was an enrichment for the MCPH1 and SESN3 promoter regions, and for THE1 elements, in the 
ChIP of human ZNF675 (Figure 3.13b). However, the ChIP of marmoset ZNF675 showed no significant 
enrichment. Since sonication of the cross-linked DNA is done before the ChIP, fragmentation of 
accessible regions, such as promoters, is more frequent than of inaccessible regions. Therefore, it is 
usual for promoter regions to be enriched in a ChIP sample. Since the control for the qPCR was a non-
coding region, the promoters’ enrichment could not be corrected. Through the analysis of the 
immunoblot, the qPCR results were confirmed (Figure 3.13c), the marmoset ZNF675 is absent, whilst 
the human ZNF675 is present, though with a very low signal. Even though the ChIP was repeated in 
U2OS cells, the results were the same (Figure 3.14). A protocol optimization is required, firstly by 
decreasing the number of washes after the IP, which might be the explanation for the loss of signal. 
However, the lack of enrichment for the cZNF675 can also be explained by the fact that this KZNF 
protein does not bind to the regions the hZNF675 binds to. Even though it would be expected, by the 
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5 Conclusion and Future Perspectives 
 
 This project aimed to elucidate the evolutionary history of ZNF675, its effect on the genes that 
were caught in the arms race, and how it relates to the human brain. The burst of THE1 and MST 
elements have occurred in the LCA of NWM and OWM, which was before the structural changes the 
ZNF675 has undergone. Together with the lack of effect by the marmoset ZNF675 towards THE1 and 
MST elements’ silencing, the human ZNF675 might have arisen in order to prevent these elements from 
transposing. When the novel ZNF675 was created, it started to bind to gene promoters, changes to 
which resulted in the evasion of repression (Figure 5.01, top), such as MCPH1, or in the stabilization of 
the regulation (Figure 5.01, bottom), such as in SESN3. Today, several neurological disorders are 
associated with mutations in both ZNF675 gene and in its regulatory targets. Thus, throughout evolution, 
modification of these genes’ expression levels by ZNF675 might have had a significant impact on the 
human brain. 




Figure 5.01 – Representation of the changes in binding capacity of ZNF675 during primate evolution. Two 
examples of promoter responses to the human ZNF675 (green) binding: evasion of repression (top) and stabilization 
of repression (bottom). 
 
 Further research remains to be done, the priority being luciferase report assays with the crab-
eating macaque MCPH1 promoter and its ZNF675, to clarify what led to the derepression of MCPH1 
during primates’ evolution. The ChIP-seq of the marmoset ZNF675 will unravel the transposable 
elements it binds to, completing the evolutionary history of ZNF675. The replacement of the ZNF675 
binding site in the human MCPH1 promoter by the marmoset is yet to be confirmed. If this strategy is 
successful, it can also be done for SESN3 promoter or any other interesting gene.  
 Furthermore, it would be interesting to investigate how ZNF675 affects cortical progenitors in a 
disease context, i.e. overexpression or knockout of ZNF675. Its effect could be assessed with a cell 
division assay in cortical progenitors, since MCPH1 is associated with the neuroprogenitors self-
renewal. Moreover, cortical organoids could be created and the MCPH1 gene expression monitored in 
different developmental stages. It is expected that the MCPH1 gene is highly expressed in the early 
stages, though in the ZNF675 overexpression condition the MCPH1 is expressed in a lower level. 
However, the MCPH1 effect would be assessed in the final developmental stages, since its deficiency 
affects the number of neurons produced, thus the size of the organoids. These assays could also be 
performed on cortical progenitor cells with the marmoset binding site for the ZNF675 in the MCPH1 
promoter, in order to confirm the changes in regulation are originated by the ZNF675. 
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 Moreover, ZNF675 KO neurons can be used to investigate the ZNF675 role in the adult brain. 
Since the SESN3 gene is described as the master regulator of pro-epileptic genes, the effect of the 
knockout or overexpression of ZNF675 can be assessed with electrophysiology. In parallel, the SESN3 
gene expression can be analysed in order to investigate if the high activity of neurons, in a ZNF675 KO 
condition, is correlated with a high expression of SESN3. This result might further associate the 
occurrence of seizures, in the patient with a deletion of ZNF675, to the SESN3 activity. 
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S.1 THE1 elements  
Table S1 – THE1B-int elements bound and not bound by ZNF675. The first column corresponds to the 
chromosomal location of 15 THE1 elements bound by ZNF675 and 15 elements not bound. The second column 
corresponds to the elements’ coordinates. The similarity score is the third column, the strand orientation and the 
length of the elements are in the fourth and fifth columns, respectively. 




chr5 61453737-61455317 13075 + 1580  
chr5 73819041-73820624 13046 + 1583  
chr5 55924010-55925584 12968 + 1574  
chr3 16028965-16030534 12952 - 1569  
chr5 6011618-6013192 12755 - 1574  
chr1 169840659-169842218 12689 + 1559  
chr3 26644529-26646113 12647 - 1584  
chr6 74391796-74393357 12617 - 1561  
chr2 99284480-99285631 12611 + 1151  
chr1 85714013-85715583 12604 - 1570  
chr5 145372393-145373969 12574 - 1576  
chr3 72112105-72113666 12561 - 1561  
chr1 60201958-60203533 12556 + 1575  
chr14 67917006-67918585 12552 + 1579  




chrX 15918445-15920029 13091 - 1584  
chr4 188409175-188410750 12906 + 1575  
chr1 46523039-46524600 12852 + 1561  
chr4 76457187-76458755 12805 - 1568  
chr10 128047807-128049388 12684 - 1581  
chr9 74904612-74905701 12614 - 1089  
chr15 70883852-70885421 12594 + 1569  
chr5 81675037-81676605 12574 - 1568  
chr7 86927549-86929126 12566 - 1577  
chr18 10942179-10943758 12547 + 1579  
chr9 80305281-80306480 12522 - 1199  
chr2 118394242-118395812 12453 + 1570  
chr5 90642949-90644522 12446 - 1573  
chr3 194240024-194241601 12432 + 1577  





S.2 MCPH1 promoter sequence conservation in basal primates  
Figure S1 – Conservation of the MCPH1 promoter region in basal primates, centred in the ZNF675 binding 
site. Comparison between sequences of human, marmoset, tarsier and basal primates (mouse lemur and 
bushbaby), using Multiple Sequence Alignment on UGENE. Shady region in the centre is the binding site of 
ZNF675. Sequences are reversed (3’ to 5’). 
